Raloxifene May Have Further Benefits in Women on Hemodialysis

Authors Information
Article Notes and Dates
To Cite : Worsley R, Gavrilidis E, Kulkarni J. Raloxifene May Have Further Benefits in Women on Hemodialysis, Int J Endocrinol Metab. 2012 ;10(4):644-645. doi: 10.5812/ijem.6580.
Copyright: Copyright © 2012, International Journal of Endocrinology and Metabolism. .
Dear Editor,
Footnotes
References
  • 1. Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando Y, et al. Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients With Type 2 Diabetes. Int J Endocrinol Metab. 2012; 10(2): 464-9[DOI]
  • 2. Weisinger JR, Bellorin-Font E. Postmenopausal osteoporosis in the dialysis patient. Curr Opin Nephrol Hypertens. 2003; 12(4): 381-6[DOI][PubMed]
  • 3. Jang C, Bell RJ, White VS, Lee PS, Dwyer KM, Kerr PG, et al. Women's health issues in haemodialysis patients. Med J Aust. 2001; 175(6): 298-301
  • 4. Preljevic VT, Osthus TB, Sandvik L, Bringager CB, Opjordsmoen S, Nordhus IH, et al. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. Gen Hosp Psychiatry. 2011; 33(5): 454-61[DOI][PubMed]
  • 5. Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol. 31(1): 56-60[DOI][PubMed]
  • 6. Joffe H, Cohen LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry. 1998; 44(9): 798-811[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check